Canadian Retinal Trials Group

The Canadian Retinal Trials Group (CRTG) is a premier national network of academic and community-based retina specialists dedicated to advancing ophthalmic research through clinical trials. Functioning as a specialized clinical research organization (CRO) and site network, CRTG provides a centralized infrastructure to streamline the conduct of multicenter clinical trials for retinal diseases across Canada. The group collaborates with global pharmaceutical and biotechnology companies to facilitate Phase 1 through Phase 4 studies, offering expertise in protocol development, site selection, and patient recruitment. Their primary focus areas include prevalent conditions such as age-related macular degeneration (AMD), diabetic retinopathy, and retinal vein occlusion. By leveraging a coordinated network of academic and private clinics, CRTG ensures high-quality data collection and efficient trial execution within the Canadian regulatory landscape.